Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 619

1.

Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines.

Baldini E, Tuccilli C, Prinzi N, Sorrenti S, Antonelli A, Gnessi L, Morrone S, Moretti C, Bononi M, Arlot-Bonnemains Y, D'Armiento M, Ulisse S.

Endocr Relat Cancer. 2014 Jul 29. pii: ERC-14-0299. [Epub ahead of print]

PMID:
25074669
[PubMed - as supplied by publisher]
2.

Dependence of bronchoconstrictor and bronchodilator responses on thoracic gas compression volume.

Pellegrino R, Antonelli A, Crimi E, Gulotta C, Torchio R, Dutto L, Pedersen OF, Brusasco V.

Respirology. 2014 Jul 14. doi: 10.1111/resp.12349. [Epub ahead of print]

PMID:
25039769
[PubMed - as supplied by publisher]
3.

[CXCR3 and CXCL10 in autoimmune thyroiditis.]

Ruffilli I, Ferrari SM, Colaci M, Ferri C, Politti U, Antonelli A, Fallahi P.

Clin Ter. 2014 May-Jun;165(3):e237-e242. doi: 10.7417/CT.2014.1727. Italian.

PMID:
24999582
[PubMed - as supplied by publisher]
4.

[The alpha chemokine "Interferon gamma-induced protein 10" (IP-10) in Graves' disease and Graves'ophthalmopathy.]

Di Domenicantonio A, Politti U, Giuggioli D, Antonelli A, Ferri C, Fallahi P.

Clin Ter. 2014 May-Jun;165(3):e230-e236. doi: 10.7417/CT.2014.1726. Italian.

PMID:
24999581
[PubMed - as supplied by publisher]
5.

IP-10 in Autoimmune Thyroiditis.

Ruffilli I, Ferrari SM, Colaci M, Ferri C, Fallahi P, Antonelli A.

Horm Metab Res. 2014 Jun 30. [Epub ahead of print]

PMID:
24977661
[PubMed - as supplied by publisher]
6.

Macrophage depletion by free bisphosphonates and zoledronate-loaded red blood cells.

Sabatino R, Antonelli A, Battistelli S, Schwendener R, Magnani M, Rossi L.

PLoS One. 2014 Jun 26;9(6):e101260. doi: 10.1371/journal.pone.0101260. eCollection 2014.

PMID:
24968029
[PubMed - in process]
Free PMC Article
7.

Personalization of targeted therapy in advanced thyroid cancer.

Fallahi P, Ferrari SM, Mazzi V, Vita R, Benvenga S, Antonelli A.

Curr Genomics. 2014 Jun;15(3):190-202. doi: 10.2174/1389202915999140404101902.

PMID:
24955027
[PubMed]
8.

Molecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules.

Fallahi P, Giannini R, Miccoli P, Antonelli A, Basolo F.

Curr Genomics. 2014 Jun;15(3):171-7. doi: 10.2174/1389202915999140404100347.

PMID:
24955024
[PubMed]
9.

"Molecular profiling and ways towards personalized medicine in advanced differentiated thyroid cancer".

Antonelli A.

Curr Genomics. 2014 Jun;15(3):161. doi: 10.2174/138920291503140609094751. No abstract available.

PMID:
24955022
[PubMed]
10.

Modulatory Effects of Peroxisome Proliferator-Activated Receptor-γ on CXCR3 Chemokines.

Ferrari SM, Antonelli A, Di Domenicantonio A, Manfredi A, Ferri C, Fallahi P.

Recent Pat Inflamm Allergy Drug Discov. 2014;8(2):132-8.

PMID:
24953713
[PubMed - in process]
11.

Targeting Chemochine (C-X-C motif) Receptor 3 in Thyroid Autoimmunity.

Fallahi P, Ferrari SM, Corrado A, Giuggioli D, Ferri C, Antonelli A.

Recent Pat Endocr Metab Immune Drug Discov. 2014 Jun 23. [Epub ahead of print]

PMID:
24953644
[PubMed - as supplied by publisher]
12.

CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo.

Antonelli A, Bocci G, La Motta C, Ferrari SM, Fallahi P, Corrado A, Fioravanti A, Sartini S, Orlandi P, Piaggi S, Corti A, Materazzi G, Galleri D, Ulisse S, Fontanini G, Danesi R, Da Settimo F, Miccoli P.

Mol Cell Endocrinol. 2014 Jun 12;393(1-2):56-64. doi: 10.1016/j.mce.2014.06.002. [Epub ahead of print]

PMID:
24931161
[PubMed - as supplied by publisher]
13.

The administration of L-thyroxine as soft gel capsule or liquid solution.

Vita R, Fallahi P, Antonelli A, Benvenga S.

Expert Opin Drug Deliv. 2014 Jul;11(7):1103-11. doi: 10.1517/17425247.2014.918101. Epub 2014 Jun 4.

PMID:
24896369
[PubMed - in process]
14.

Thyroid dysfunctions induced by tyrosine kinase inhibitors.

Fallahi P, Ferrari SM, Vita R, Di Domenicantonio A, Corrado A, Benvenga S, Antonelli A.

Expert Opin Drug Saf. 2014 Jun;13(6):723-33. doi: 10.1517/14740338.2014.913021. Epub 2014 May 12.

PMID:
24821006
[PubMed - in process]
15.

Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine.

Corrado A, Ferrari SM, Ferri C, Ferrannini E, Antonelli A, Fallahi P.

Clin Ter. 2014;165(2):e181-5. doi: 10.7471/CT.2014.1706.

PMID:
24770831
[PubMed - in process]
16.

[The alpha chemokine "Interferon gamma-induced protein 10" (IP-10) in Graves' disease].

Mancusi C, Di Domenicantonio A, Politti U, Giuggioli D, Antonelli A, Ferri C, Fallahi P.

Clin Ter. 2014;165(2):e174-80. doi: 10.7471/CT.2014.1705. Italian.

PMID:
24770830
[PubMed - in process]
17.

Mechanical correlates of dyspnea in bronchial asthma.

Antonelli A, Crimi E, Gobbi A, Torchio R, Gulotta C, Dellaca R, Scano G, Brusasco V, Pellegrino R.

Physiol Rep. 2013 Dec 8;1(7):e00166. doi: 10.1002/phy2.166. eCollection 2013 Dec 1.

PMID:
24744853
[PubMed]
Free PMC Article
18.

Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia.

Fallahi P, Ferrari SM, Giuggioli D, Manfredi A, Mancusi C, Fabiani S, Centanni M, Marchi S, Ferri C, Antonelli A.

Hormones (Athens). 2014 Jan-Mar;13(1):16-23.

PMID:
24722124
[PubMed - in process]
Free Article
19.

USPIO-loaded red blood cells as a biomimetic MR contrast agent: a relaxometric study.

Boni A, Ceratti D, Antonelli A, Sfara C, Magnani M, Manuali E, Salamida S, Gozzi A, Bifone A.

Contrast Media Mol Imaging. 2014 May-Jun;9(3):229-36. doi: 10.1002/cmmi.1562.

PMID:
24700750
[PubMed - in process]
20.

Open partial horizontal laryngectomies: a proposal for classification by the working committee on nomenclature of the European Laryngological Society.

Succo G, Peretti G, Piazza C, Remacle M, Eckel HE, Chevalier D, Simo R, Hantzakos AG, Rizzotto G, Lucioni M, Crosetti E, Antonelli AR.

Eur Arch Otorhinolaryngol. 2014 Apr 2. [Epub ahead of print]

PMID:
24691854
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk